课题基金 / 基金详情

HETEROGENEITY OF ALPHA-2 ADRENERGIC RECEPTORS

HETEROGENEITY OF ALPHA-2 ADRENERGIC RECEPTORS
ALPHA-2 肾上腺素能受体的异质性
批准号:
3298705
负责人:
DAVID B BYLUND
金额:
$18.52万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1993-06-30

项目摘要

项目成果

DAVID B BYLUND的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alpha-2 adrenergic receptors mediate several important functions of the endogenous catecholamines in both the central and peripheral nervous systems. Several clinically important drugs appear to produce their pharmacologic effects through an interaction at alpha-2 receptors. There now exists considerable evidence indicating significant differences in the pharmacological characteristics and regulation of mammalian alpha-2 adrenergic receptors from various tissues and species. We suggest that differences in the pharmacological properties and in the regulation (mechanism of action) of alpha-2 adrenergic receptors may be due to differences in the structure of the alpha-2 adrenergic receptor complex. To test this hypothesis, it is proposed to compare in various tissues and species: (1) The rank order and relative potencies of various adrenergic drugs using both radioligand binding and functional assays; (2) The thermal stability and pH optima of radioligand binding; (3) The functional size of the receptor complex using target analysis (radiation inactivation); (4) The apparent molecular size determined by gel filtration and sucrose density gradient centrifugation of receptor preparations solubilized in the presence and absence of agonist; and (5) The apparent molecular weight from SDS gel electrophoresis of partially purified receptors labeled with a photoaffinity probe. These studies should help to resolve the present confusion in classification of alpha receptors and may lead to more selective alpha adrenergic drugs for clinical use.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Down-regulation of alpha 2-adrenoceptor subtypes.
α2-肾上腺素受体亚型的下调。
DOI: 10.1016/0922-4106(93)90024-4
发表时间: 1993
期刊: European journal of pharmacology
影响因子: 5
作者: [Pleus,RC, Shreve,PE, Toews,ML, Bylund,DB]
通讯作者: Bylund,DB
Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line.
负鼠肾脏和 OK 细胞系中 α-2C 肾上腺素能受体亚型的表征。
DOI: --
发表时间: 1991
期刊: The Journal of pharmacology and experimental therapeutics
影响因子: --
作者: [Blaxall,HS, Murphy,TJ, Baker,JC, Ray,C, Bylund,DB]
通讯作者: Bylund,DB
Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
[3H]RX821002 与 α-2 肾上腺素能受体亚型结合的表征。
DOI: --
发表时间: 1994
期刊: The Journal of pharmacology and experimental therapeutics
影响因子: --
作者: [O'Rourke,MF, Blaxall,HS, Iversen,LJ, Bylund,DB]
通讯作者: Bylund,DB
Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.
α-2A 肾上腺素能受体的物种直系同源物:牛和大鼠受体的药理学特性不同于人和猪受体。
DOI: --
发表时间: 1994
期刊: The Journal of pharmacology and experimental therapeutics
影响因子: --
作者: [O'Rourke,MF, Iversen,LJ, Lomasney,JW, Bylund,DB]
通讯作者: Bylund,DB
9
    Short Course: Integrative and Organ Systems Pharmacology
    Short Course: Integrative and Organ Systems Pharmacology
    Short Course: Integrative and Organ Systems Pharmacology
    Short Course: Integrative and Organ Systems Pharmacology
    海外基金